Company Description Xyall is a venture-backed molecular diagnostics scale-up founded in 2018. The company delivers advanced solutions that improve the precision and efficiency of tumor tissue selection for molecular testing, directly supporting optimized cancer treatment decisions. Role Description Xyall
About Xyall Xyall is a Dutch medtech scale-up headquartered in Eindhoven, with a commercial organization in the United States. We develop, manufacture, and commercialize innovative molecular pathology solutions for cancer diagnostics. Our solutions contribute to more targeted cancer
Xyall is a Dutch medtech scale-up headquartered in Eindhoven, with a commercial organization in the United States. We develop, manufacture, and commercialize innovative molecular pathology solutions for cancer diagnostics. Vaardigheden, ervaring, kwalificaties: als u de juiste match bent